EpiQMAx GmbH, Großhaderner Straße 9, 82152 Planegg-Martinsried, Germany.
Institute for Laboratory Medicine, German Heart Centre, Technical University Munich, Lazarettstraße 36, 80636 Munich, Germany.
Stem Cell Reports. 2020 Dec 8;15(6):1196-1205. doi: 10.1016/j.stemcr.2020.11.002.
Human stem cells bear a great potential for multiple therapeutic applications but at the same time constitute a major threat to human health in the form of cancer stem cells. The molecular processes that govern stem cell maintenance or differentiation have been extensively studied in model organisms or cell culture, but it has been difficult to extrapolate these insights to therapeutic applications. Recent advances in the field suggest that local and global changes in histone modifications that affect chromatin structure could influence the capability of cells to either maintain their stem cell identity or differentiate into specialized cell types. The enzymes that regulate these modifications are therefore among the prime targets for potential drugs that can influence and potentially improve the therapeutic application of stem cells. In this review, we discuss recent findings on the role of histone modifications in stem cell regulation and their potential implications for clinical applications.
人类干细胞具有广泛的治疗应用潜力,但同时也构成了以癌症干细胞形式对人类健康的重大威胁。在模式生物或细胞培养中,已经对控制干细胞维持或分化的分子过程进行了广泛研究,但将这些见解推断到治疗应用中一直很困难。该领域的最新进展表明,影响染色质结构的组蛋白修饰的局部和全局变化可能会影响细胞维持其干细胞特性或分化为特定细胞类型的能力。因此,调节这些修饰的酶是潜在药物的主要靶标之一,这些药物可以影响和潜在改善干细胞的治疗应用。在这篇综述中,我们讨论了组蛋白修饰在干细胞调控中的作用及其对临床应用的潜在意义。